Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multiparametric MRI for Assessing Breast Cancer Response to Anti-HER2 Therapy

NCT03738553 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT03738553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03738553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multiparametric MRI for Assessing Breast Cancer Response to Anti-HER2 Therapy
Lead sponsor
University of Washington
Phase
Observational
Overall status
Terminated
Start date
August 31, 2013
Completion date
March 1, 2026
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

her2-positive breast cancer